Pancreatic Cancer Research

ResearcherWest China Medical Center of Sichuan UniversityActive in the last 2 years

Qiangxing Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6272-2362; OpenAlex author ID A5023564135. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 2 papers · 2025: 1 paper

Papers 3

  1. PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. First author DOI 10.1007/s11010-024-05078-x↗
  2. CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-57417-z↗
  3. Dual and triple gene combinations of KRT5, KRT17, and S100A2 identify basal-like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcom… Co-author DOI 10.1096/fj.202302484rr↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xin Wang · 3 shared papers, 2024–2025 · strength 0.60
  2. Bing Peng · 2 shared papers, 2024–2025 · strength 0.42
  3. Ke Cheng · 2 shared papers, 2024–2025 · strength 0.42
  4. He Cai · 2 shared papers, 2024–2025 · strength 0.42
  5. Ke Cheng · 1 shared paper, 2024 · strength 0.18
  6. Zhong Wu · 1 shared paper, 2024 · strength 0.18
  7. Bing Peng · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.